Rocky Mountain Ayre, Inc. (RMTN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rocky Mountain Ayre, Inc. (RMTN) trades at $0.00 with AI Score 53/100 (Grade B). Rocky Mountain Ayre, Inc. operates in the financial services sector, with involvement in food, hospitality, manufacturing, medical marijuana, and retail. Market cap: $6,049, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for RMTN: RMTN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RMTN against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
RMTN: 3/6 perspectives are bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Rocky Mountain Ayre, Inc. (RMTN) Financial Services Profile
Rocky Mountain Ayre, Inc., operating in the financial services sector, engages in diverse ventures including food, hospitality, manufacturing, medical marijuana, and retail. Headquartered in Dover, Delaware, the company's financial profile reveals a challenging profitability landscape with a negative P/E ratio and substantial negative profit margin, contrasting with a high gross margin.
What Is the Investment Thesis for RMTN?
Investing in Rocky Mountain Ayre, Inc. presents a high-risk, high-reward scenario. The company's diversification across multiple sectors—food and hospitality, manufacturing, medical marijuana, and retail—could provide resilience against downturns in any single industry. However, the current financial metrics raise concerns. The negative P/E ratio of -0.02 and a profit margin of -3611.9% indicate significant losses. A gross margin of 100.0% suggests potential in core operations, but overhead and other expenses are overwhelming revenue. The high beta of 6.40 indicates extreme volatility relative to the market. Potential investors should closely monitor the company's ability to achieve profitability and manage its diverse operations effectively. Key catalysts include successful expansion in the medical marijuana sector and improved operational efficiencies. The company's ability to restructure its operations and achieve profitability is crucial for long-term sustainability.
Based on FMP financials and quantitative analysis
RMTN Key Highlights
- Market capitalization of 6K indicates a micro-cap company with limited market presence.
- Negative P/E ratio of -0.02 suggests the company is currently unprofitable.
- Profit margin of -3611.9% indicates significant losses relative to revenue.
- Gross margin of 100.0% suggests strong potential in core operations before considering overhead and other expenses.
- Beta of 6.40 indicates high volatility compared to the overall market.
Who Are RMTN's Competitors?
RMTN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CAVG ACC Aviation Holdings Ltd. | $1.25 | +0.00% | $16.03M | 44 |
| IREN IREN Limited | $43.70 | +12.58% | $15.60B | 70 |
| DOMH Dominari Holdings Inc. | $2.96 | +0.51% | $47.60M | 65 |
| DEFT DeFi Technologies Inc. | $0.53 | -0.83% | $171.18M | 65 |
| COHN Cohen & Company Inc. | $13.25 | +0.99% | $27.79M | 65 |
| JRJC China Finance Online Co. Limited | $3.99 | -38.33% | 54 | |
| ABGSF ABG Sundal Collier Holding ASA | $0.72 | +0.00% | $371.26M | 54 |
| DSECF Daiwa Securities Group Inc. | $9.69 | +0.00% | $13.43B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RMTN's Key Strengths?
- Diversified business operations across multiple sectors.
- Existing presence in the food and hospitality industry.
- Potential early mover advantage in the medical marijuana market.
- High gross margin of 100.0% indicates potential in core operations.
What Are RMTN's Weaknesses?
- Significantly negative profit margin indicates financial instability.
- Negative P/E ratio suggests the company is currently unprofitable.
- High beta indicates extreme volatility.
- Limited market capitalization restricts access to capital.
What Could Drive RMTN Stock Higher?
- Potential expansion and revenue generation from the medical marijuana sector, contingent on regulatory approvals and market acceptance.
- Implementation of operational efficiency improvements to reduce losses and improve profitability.
- Potential strategic partnerships and acquisitions to expand market reach and product offerings.
- Development and implementation of proprietary technologies to gain a competitive edge.
- Geographic expansion into new markets to access new customers and revenue streams.
What Are the Key Risks for RMTN?
- Significant financial losses and negative profit margin raise concerns about the company's long-term viability.
- Intense competition in all sectors it operates in could limit growth potential.
- Regulatory challenges in the medical marijuana market could hinder expansion plans.
- Economic downturns affecting consumer spending could negatively impact revenue.
- Limited information and transparency due to OTC Other listing increases investment risk.
What Are the Growth Opportunities for RMTN?
- Expansion in the Medical Marijuana Sector: The medical marijuana industry is projected to reach $55 billion by 2026, offering significant growth potential for RMTN. Successful expansion in this sector requires navigating complex regulatory landscapes and establishing strong distribution networks. RMTN's existing infrastructure in other sectors could provide a competitive advantage, allowing for efficient resource allocation and market penetration. The timeline for realizing substantial revenue from this sector is estimated at 2-3 years, contingent on regulatory approvals and market acceptance.
- Operational Efficiency Improvements: With a gross margin of 100.0% but a significantly negative profit margin, RMTN has substantial room for improvement in operational efficiency. Streamlining operations across its diverse business segments and reducing overhead costs could significantly improve profitability. Implementing lean management principles and investing in automation technologies could drive cost savings and improve overall efficiency. The timeline for achieving significant operational improvements is estimated at 1-2 years, dependent on management's commitment and effective implementation of cost-cutting measures.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with established players in the food, hospitality, and retail sectors could provide RMTN with access to new markets and technologies. Acquiring complementary businesses could expand its product offerings and customer base. Careful due diligence and integration planning are crucial for successful partnerships and acquisitions. The timeline for realizing benefits from strategic partnerships and acquisitions is estimated at 2-3 years, contingent on identifying suitable partners and successful integration.
- Development of Proprietary Technologies: Investing in the development of proprietary technologies for its various business segments could provide RMTN with a competitive edge. For example, developing innovative food processing technologies or advanced retail analytics platforms could differentiate the company from its competitors. The timeline for developing and implementing proprietary technologies is estimated at 3-5 years, requiring significant investment in research and development.
- Geographic Expansion: Expanding its operations beyond its current geographic footprint could provide RMTN with access to new markets and customers. Identifying regions with favorable regulatory environments and strong growth potential is crucial for successful geographic expansion. Careful market research and adaptation to local market conditions are essential for success. The timeline for realizing benefits from geographic expansion is estimated at 2-4 years, dependent on market conditions and regulatory approvals.
What Opportunities Does RMTN Have?
- Expansion in the rapidly growing medical marijuana market.
- Improvement of operational efficiency to reduce losses.
- Strategic partnerships and acquisitions to expand market reach.
- Development of proprietary technologies to gain a competitive edge.
What Threats Does RMTN Face?
- Intense competition in all sectors it operates in.
- Regulatory challenges in the medical marijuana market.
- Economic downturns affecting consumer spending.
- Inability to achieve profitability despite diversification.
What Are RMTN's Competitive Advantages?
- Diversification across multiple sectors provides some resilience against downturns in specific industries.
- Existing restaurant operation provides a foundation for expansion in the food and hospitality sector.
- Early entry into the medical marijuana market (subject to regulatory approvals) could provide a first-mover advantage.
What Does RMTN Do?
Rocky Mountain Ayre, Inc., originally founded in 1999 as AyreTrade, Inc., underwent a name change in February 2015 to reflect its evolving business interests. Headquartered in Dover, Delaware, the company operates through its subsidiaries, engaging in a diverse range of industries including food and hospitality, manufacturing, medical marijuana, and retail. Its operations include a restaurant located in Agawam, Massachusetts. This diversification indicates a strategic attempt to establish a presence across multiple sectors, potentially to mitigate risks associated with individual market fluctuations. However, the company's financial performance, characterized by a negative price-to-earnings ratio and a significantly negative profit margin, suggests underlying challenges in achieving profitability across its various ventures. The company's ability to effectively manage and integrate these diverse operations will be critical to its future success and financial stability. The shift from its original identity as AyreTrade, Inc. signals a significant strategic pivot, necessitating careful evaluation of its current business model and market positioning.
What Products and Services Does RMTN Offer?
- Operates in the financial services sector.
- Engages in food and hospitality businesses.
- Participates in the manufacturing industry.
- Involved in the medical marijuana sector.
- Operates retail businesses.
- Manages a restaurant in Agawam, Massachusetts.
How Does RMTN Make Money?
- Generates revenue through its food and hospitality operations, including restaurant sales.
- Derives income from its manufacturing activities.
- Seeks to generate revenue from the medical marijuana industry.
- Obtains revenue from its retail businesses.
What Industry Does RMTN Operate In?
Rocky Mountain Ayre, Inc. operates within the financial services sector, which is currently experiencing increased regulatory scrutiny and technological disruption. The company's diversification into various industries like food, hospitality, and medical marijuana positions it uniquely compared to traditional financial firms. Competitors such as BFCH, CAVG, CNER, GMNI, and HAON are focused on specific segments within the broader financial landscape. The company's ability to navigate these diverse markets and achieve profitability will be critical in a competitive environment characterized by evolving consumer preferences and regulatory changes.
Who Are RMTN's Key Customers?
- Restaurant patrons in Agawam, Massachusetts.
- Consumers of its manufactured goods.
- Customers in the medical marijuana market (subject to regulatory approvals).
- Retail consumers.
How Rocky Mountain Ayre, Inc. Is Valued
Rocky Mountain Ayre, Inc. carries a market capitalization of 6K, placing it in the micro-cap category. Relative to its peer group, RMTN's quantitative score of 53/100 is roughly in line with the peer average of 62/100.
Company Profile
Rocky Mountain Ayre, Inc. operates in the Financial - Capital Markets industry within the Financial Services sector. It is headquartered in Dover, US. The company is led by CEO Gregory Sullivan. RMTN has traded publicly since 2002.
ROE 416%Key Financial Metrics
Return on equity for Rocky Mountain Ayre, Inc. stands at 416.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -76.3%, showing how much profit it generates from its asset base. A current ratio of 1.10 indicates the company holds enough short-term assets to cover its near-term obligations.
RMTN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diversified business operations across multiple sectors.
- Existing presence in the food and hospitality industry.
- Potential early mover advantage in the medical marijuana market.
- High gross margin of 100.0% indicates potential in core operations.
Bear Case
- Significantly negative profit margin indicates financial instability.
- Negative P/E ratio suggests the company is currently unprofitable.
- High beta indicates extreme volatility.
- Limited market capitalization restricts access to capital.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
RMTN Latest News
No recent news available for RMTN.
RMTN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RMTN.
Price Targets
Wall Street price target analysis for RMTN.
RMTN MoonshotScore
What does this score mean?
The MoonshotScore rates RMTN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Gregory Sullivan
CEO
Gregory Sullivan serves as the CEO of Rocky Mountain Ayre, Inc. His background and prior experience are not detailed in the provided data. Therefore, a comprehensive understanding of his qualifications and expertise in leading a diversified company across financial services, food, hospitality, manufacturing, medical marijuana, and retail sectors is limited. Further information regarding his educational background, previous roles, and relevant industry experience is needed to fully assess his suitability for the role.
Track Record: Due to the limited information available, it is not possible to assess Gregory Sullivan's track record at Rocky Mountain Ayre, Inc. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown. Further data is needed to evaluate his performance and contribution to the company's strategic direction and financial outcomes.
RMTN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for trading on OTCQX or OTCQB. Companies in this tier often have limited or no public information available, and may not meet minimum financial standards. Investing in OTC Other securities carries significant risks due to the lack of transparency and regulatory oversight. These companies are not required to adhere to the same reporting standards as those listed on major exchanges like the NYSE or NASDAQ, leading to increased information asymmetry and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no public information available.
- Lack of regulatory oversight and reporting requirements.
- Low trading volume and wide bid-ask spreads.
- Increased risk of price manipulation and fraud.
- Potential for delisting or suspension of trading.
- Verify the company's registration and legal standing.
- Attempt to obtain financial statements and other relevant information.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC Other securities.
- Consult with a financial advisor before investing.
- Be prepared to lose your entire investment.
- Company has been in operation since 1999.
- Company has a registered headquarters in Dover, Delaware.
- Company has a CEO (Gregory Sullivan).
Rocky Mountain Ayre, Inc. Financial Services Stock: Key Questions Answered
What does Rocky Mountain Ayre, Inc. do?
Rocky Mountain Ayre, Inc. operates as a diversified holding company with interests spanning across multiple sectors, including food and hospitality, manufacturing, medical marijuana, and retail. The company's business model involves managing and operating subsidiaries in these diverse industries, aiming to generate revenue through their respective activities. Its operations include a restaurant in Agawam, Massachusetts, and potential ventures in the medical marijuana market, contingent on regulatory approvals. The company's diversification strategy seeks to mitigate risks associated with individual market fluctuations, but its overall success depends on effective management and operational efficiency across its various business segments.
What do analysts say about RMTN stock?
As of 2026-03-17, there is no available analyst coverage or consensus on Rocky Mountain Ayre, Inc. (RMTN) stock. This lack of coverage is typical for micro-cap companies trading on the OTC market. Investors should rely on their own due diligence and research to assess the company's prospects and risks. Key valuation metrics, such as price-to-earnings ratio and profit margin, indicate significant financial challenges. Growth considerations should focus on the company's ability to achieve profitability and successfully expand in its various business segments. The absence of analyst opinions underscores the high-risk nature of investing in RMTN.
What are the main risks for RMTN?
Rocky Mountain Ayre, Inc. faces several significant risks, primarily stemming from its financial instability and operational challenges. The company's negative profit margin and P/E ratio indicate substantial losses and raise concerns about its long-term viability. Its diversification across multiple sectors exposes it to various industry-specific risks, including regulatory hurdles in the medical marijuana market and economic downturns affecting consumer spending. Furthermore, as an OTC-listed company with limited information and transparency, RMTN carries additional risks related to liquidity, price manipulation, and potential fraud. Investors should carefully consider these risks before investing in RMTN.
What are the key factors to evaluate for RMTN?
Rocky Mountain Ayre, Inc. (RMTN) holds an AI score of 53/100 (moderate). Not financial advice.
How frequently does RMTN data refresh on this page?
RMTN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RMTN's recent stock price performance?
Rocky Mountain Ayre, Inc. (RMTN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business operations across multiple sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RMTN overvalued or undervalued right now?
Valuing Rocky Mountain Ayre, Inc. (RMTN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RMTN?
Before investing in Rocky Mountain Ayre, Inc. (RMTN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Financial data may not be fully up-to-date or audited.